1-155904496-A-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_006912.6(RIT1):c.244T>A(p.Phe82Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F82C) has been classified as Pathogenic.
Frequency
Consequence
NM_006912.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIT1 | NM_006912.6 | c.244T>A | p.Phe82Ile | missense_variant | Exon 5 of 6 | ENST00000368323.8 | NP_008843.1 | |
RIT1 | NM_001256821.2 | c.295T>A | p.Phe99Ile | missense_variant | Exon 5 of 6 | NP_001243750.1 | ||
RIT1 | NM_001256820.2 | c.136T>A | p.Phe46Ile | missense_variant | Exon 4 of 5 | NP_001243749.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Noonan syndrome 8 Pathogenic:3
This variant has been previously reported in the literature as c.244T>A (p.Phe82Ile) on the alternative transcript NM_006912.5. This variant has been previously reported as a heterozygous germline variant in one individual with Noonan Syndrome (PMID: 26757980). This variant has also been previously reported as a somatic variant in myeloid malignancies (PMID: 23765226). However, other variants affecting the same amino acid residue have been reported in ClinVar as Pathogenic variants (Variation ID: 183407, 183408, 372863, 694696, 181522, 370035). This variant is absent from the gnomAD population database and thus is presumed to be rare. The c.295T>A (p.Phe99Ile) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.295T>A (p.Phe99Ile) variant is classified as Pathogenic. -
This sequence change replaces phenylalanine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 82 of the RIT1 protein (p.Phe82Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of Noonan syndrome (PMID: 26757980; Invitae). ClinVar contains an entry for this variant (Variation ID: 183406). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is expected to disrupt RIT1 function with a positive predictive value of 95%. This variant disrupts the p.Phe82 amino acid residue in RIT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23791108, 24939608, 25049390, 26757980). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:1
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26757980, 23765226) -
Noonan syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at